对免疫检查点封锁的反应,耐药性和毒性
Golnaz Morad1, Beth A Helmink2, Padmanee Sharma3
1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cell
|October 8, 2021
概括
免疫检查点阻塞 (ICB) 在癌症治疗中具有前景,但反应率和副作用有限. 了解宿主因素和暴露基是提高ICB有效性和安全性的关键.
科学领域:
- 癌症学
- 免疫学
- 遗传学
背景情况:
- 免疫检查点阻断 (ICB) 已经彻底改变了癌症治疗,
- 与ICB相关的免疫相关不良事件 (irAEs) 可能需要停止治疗,强调需要更好的预测和管理策略.
研究的目的:
- 审查目前对影响ICB反应和毒性的宿主内在和外在因素的理解.
- 确定ICB治疗中反应,耐药性和不良事件的关键决定因素.
主要方法:
- 关于研究宿主因子 (基因组,表观基因组,免疫) 和与ICB相关的暴露基因组的综合文献审查.
- 对宿主-免疫-瘤共同进化的分析.
主要成果:
- 宿主内在因素,包括遗传和表观遗传特征和免疫状况,对ICB结果产生重大影响.
- 暴露组包括内部和外部暴露,在调节宿主生理和对ICB的反应中起着至关重要的作用.
- 综合了解这些因素可以了解ICB反应,耐药性和毒性的特征.
结论:
- 对宿主内在因素和暴露基的进一步研究对于优化ICB疗效和减轻毒性至关重要.
- 利用这些见解可以制定个性化治疗策略,改善癌症免疫疗法的患者结果.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
4.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
741
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
741
T Cell Activation and Clonal Selection
9.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
9.8K
Immune Response Against Viral Pathogens
1.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.1K
Cell-mediated Immune Responses
75.9K
Overview
75.9K


